Downgrading Idec to Accumulate

Also analysts' opinions on FTI, Gateway and Altera

Idec Pharmaceuticals (IDPH) Downgrading to 4 STARS (accumulate), from 5 STARS (buy)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.